|
Volumn 131, Issue 49 SUPPL. 9, 2006, Pages
|
Current recommendations for the diagnosis and treatment of pulmonary hypertension;Derzeitige empfehlungen zur diagnostik und therapie der pulmonalen hypertonie
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BOSENTAN;
CALCIUM ANTAGONIST;
CATECHOLAMINE;
DIURETIC AGENT;
ENDOTHELIN RECEPTOR ANTAGONIST;
ILOPROST;
PHOSPHODIESTERASE V INHIBITOR;
PROSTACYCLIN;
PROSTANOID;
SILDENAFIL;
SITAXSENTAN;
UNIPROST;
ALGORITHM;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIAGNOSTIC TEST;
DISEASE ASSOCIATION;
ECHOCARDIOGRAPHY;
ENDARTERECTOMY;
HEART DISEASE;
HEART FAILURE;
HEART LEFT VENTRICLE;
HUMAN;
LUNG DISEASE;
LUNG EMBOLISM;
PROGNOSIS;
PULMONARY HYPERTENSION;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
3',5'-CYCLIC-GMP PHOSPHODIESTERASE;
ALGORITHMS;
ANTIHYPERTENSIVE AGENTS;
CALCIUM CHANNEL BLOCKERS;
ECHOCARDIOGRAPHY, DOPPLER;
ECHOCARDIOGRAPHY, STRESS;
ENDARTERECTOMY;
ERGOMETRY;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYPERTENSION, PULMONARY;
LUNG DISEASES;
PROSTAGLANDINS;
PULMONARY EMBOLISM;
RECEPTORS, ENDOTHELIN;
VASODILATOR AGENTS;
VENTRICULAR DYSFUNCTION, LEFT;
VENTRICULAR DYSFUNCTION, RIGHT;
|
EID: 33846271472
PISSN: 00120472
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2006-957206 Document Type: Review |
Times cited : (5)
|
References (2)
|